Sofinnova Investments, Inc. Ikena Oncology, Inc. Transaction History
Sofinnova Investments, Inc.
- $1.36 Billion
- Q1 2025
A detailed history of Sofinnova Investments, Inc. transactions in Ikena Oncology, Inc. stock. As of the latest transaction made, Sofinnova Investments, Inc. holds 382,616 shares of IKNA stock, worth $512,705. This represents 0.04% of its overall portfolio holdings.
Number of Shares
382,616
Previous 382,616
-0.0%
Holding current value
$512,705
Previous $627,000
22.01%
% of portfolio
0.04%
Previous 0.05%
Shares
3 transactions
Others Institutions Holding IKNA
# of Institutions
48Shares Held
33.8MCall Options Held
0Put Options Held
0-
Atlas Venture Life Science Advisors, LLC5.02MShares$6.72 Million1.88% of portfolio
-
Blue Owl Capital Holdings LP New York, NY4.09MShares$5.48 Million2.71% of portfolio
-
Bvf Inc San Francisco, CA4.01MShares$5.37 Million0.23% of portfolio
-
Bml Capital Management, LLC Zionsville, IN3.71MShares$4.97 Million3.84% of portfolio
-
Orbimed Advisors LLC San Diego, CA3.54MShares$4.74 Million0.14% of portfolio
About Ikena Oncology, Inc.
- Ticker IKNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,257,500
- Market Cap $48.6M
- Description
- Ikena Oncology, Inc., a targeted oncology company, focuses on developing medicines tailored to biomarker-defined patient groups for specific unmet needs. Its lead targeted oncology product candidate is IK-930, an oral small molecule inhibitor of the transcriptional enhanced associate domain, transcription factor in the Hippo signaling pathway. I...